Available studies (276 found)
Short citation | Full citation | Bioassay | Epidemiology | Epi. meta-analysis | In vitro | Ecology |
---|---|---|---|---|---|---|
Cao W et al. 2018 | Cao W, Liu X, Liu X, Zhou Y, Zhang X, Tian H, Wang J, Feng S, Wu Y, Bhatti P, Wen S, Sun X. Perfluoroalkyl substances in umbilical cord serum and gestational and postnatal growth in a Chinese birth cohort. Environment International 116:197-205. HERO DOI | |||||
Case, York, and Christian 2001, 1291129 | Case MT, York RG, and Christian MS. Rat and rabbit oral developmental toxicology studies with two perfluorinated compounds. International Journal of Toxicology 20:101-109. HERO DOI | |||||
Charles D et al. 2020, 7068869 | Charles D, Berg V, Nøst TH, Huber S, Sandanger TM, Rylander C, ,. Pre- and post-diagnostic blood profiles of perfluoroalkyl acids in type 2 diabetes mellitus cases and controls. Environment International 145:106095. HERO DOI PubMed | |||||
Chen L et al. 2020, 7263985 | Chen L, Tong C, Huo X, Zhang J, Tian Y. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and birth outcomes: A longitudinal cohort with repeated measurements. Chemosphere 267:128899. HERO DOI PubMed | |||||
Chen MH et al. 2012 | Chen MH, Ha EH, Wen TW, Su YN, Lien GW, Chen CY, Chen PC, Hsieh WS. Perfluorinated compounds in umbilical cord blood and adverse birth outcomes. PLoS ONE 7:e42474. HERO | |||||
Chen Q et al. 2018 | Chen Q, Huang R, Hua L, Guo Y, Huang L, Zhao Y, Wang X, Zhang J. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood atopic dermatitis: a prospective birth cohort study. HERO | |||||
Chen Q et al. 2019 | Chen Q, Zhang X, Zhao Y, Lu W, Wu J, Zhao S, Zhang J, Huang L. Prenatal exposure to perfluorobutanesulfonic acid and childhood adiposity: A prospective birth cohort study in Shanghai, China. Chemosphere 226:17-23. HERO DOI | |||||
Christensen KY et al. 2011 | Christensen KY, Maisonet M, Rubin C, Holmes A, Calafat AM, Kato K, Flanders WD, Heron J, Mcgeehin MA, Marcus M. Exposure to polyfluoroalkyl chemicals during pregnancy is not associated with offspring age at menarche in a contemporary British cohort. Environment International 37:129-135. HERO DOI | |||||
Christensen KY et al. 2016a | Christensen KY, Raymond M, Thompson BA, Anderson HA. Perfluoroalkyl substances in older male anglers in Wisconsin. Environment International 91:312-318. HERO | |||||
Christensen KY et al. 2016b | Christensen KY, Raymond MR, Thompson BA, Anderson HA. Fish consumption, levels of nutrients and contaminants, and endocrine-related health outcomes among older male anglers in Wisconsin. Journal of Occupational and Environmental Medicine 58:668-675. HERO DOI | |||||
Christensen KY, Raymond M, and Meiman J 2019 | Christensen KY, Raymond M, Meiman J. Perfluoroalkyl substances and metabolic syndrome. International Journal of Hygiene and Environmental Health 222:147-153. HERO DOI | |||||
Covance 2000, 5385932 | Covance Laboratories. Support: 13-week dietary toxicity study with n-methyl perfluorooctanesulfonamido ethanol (N-MeFOSE, T-6314) in rats, with cover letter dated 072400. (EPA/OTS Doc #FYI-OTS-0700-1378). St. Paul, MN: 3M. HERO | |||||
Cui et al. 2021, 9944359 | Cui Shu, Zhao X, Chu X, Zhang S, Gu Q, Xu C. Effect of polyfluoroalkyl chemicals on the occurrence of urge urinary incontinence: a population-based study. Therapeutic Advances in Urology 13. HERO DOI | |||||
Donat-Vargas C et al. 2019a | Donat-Vargas C, Bergdahl IA, Tornevi A, Wennberg M, Sommar J, Kiviranta H, Koponen J, Rolandsson O, Åkesson A. Perfluoroalkyl substances and risk of type II diabetes: A prospective nested case-control study. Environment International 123:390-398. HERO DOI | |||||
Donat-Vargas C et al. 2019b | Donat-Vargas C, Bergdahl IA, Tornevi A, Wennberg M, Sommar J, Koponen J, Kiviranta H, Åkesson A. Associations between repeated measure of plasma perfluoroalkyl substances and cardiometabolic risk factors. Environment International 124:58-65. HERO DOI | |||||
Dong GH et al. 2013 | Dong GH, Tung KY, Tsai CH, Liu MM, Wang D, Liu W, Jin YH, Hsieh WS, Lee YL, Chen PC. Serum polyfluoroalkyl concentrations, asthma outcomes, and immunological markers in a case-control study of Taiwanese children. Environmental Health Perspectives 121:507-13, 513e1-8. HERO | |||||
Duan et al. 2021, 7751044 | Duan Y, Sun H, Yao Y, Li Y, Meng Y, Lu Y, Han L, Chen L. Serum concentrations of per-/polyfluoroalkyl substances and risk of type 2 diabetes: A case-control study. Science of the Total Environment 787:147476. HERO DOI | |||||
Duan Y et al. 2020 | Duan Y, Sun H, Yao Y, Meng Y, Li Y. Distribution of novel and legacy per-/polyfluoroalkyl substances in serum and its associations with two glycemic biomarkers among Chinese adult men and women with normal blood glucose levels. Environment International 134:105295. HERO DOI | |||||
Dupont, 1991, 5380491 | Subchronic inhalation toxicity: four-week study with hcfc-124 (ethane, 2-chloro-1,1,1,2-tetrafluoro-), inhalation study with rats, with cover letter dated 1/29/1991 (sanitized). HERO | |||||
Dupont 1991, 5381147 | Dupont Chemicals Inc. Pilot Teratogenicity Study of Hcfc-124 in the Rat with Cover Letter (sanitized). HERO | |||||
ECHA, 1976, 6299236 | European Chemicals Agency (ECHA). Registration dossier: 1,1,1,2,2,3,3-heptafluoro-3-[(trifluorovinyl)oxy]propane (CASRN: 1623-05-8): Acute toxicity: oral: 002 Supporting | Experimental result. HERO | |||||
ECHA, 1992, 6299232 | European Chemicals Agency (ECHA). Registration dossier: 2,2,3,3,5,5,6,6-octafluoro-4-(trifluoromethyl)morpholine (CASRN: 382-28-5): Acute toxicity: oral: 001 Key | Experimental result. HERO | |||||
ECHA, 1995, 6299219 | European Chemicals Agency (ECHA). RRegistration dossier: Trifluoromethanesulphonic acid (CASRN: 1493-13-6): Repeated dose toxicity: oral: 001 Key | Experimental result. HERO | |||||
ECHA, 1995, 6299239 | European Chemicals Agency (ECHA). Registration dossier: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctanesulphonic acid (CASRN: 27619-97-2): Repeated dose toxicity: oral: 003 Supporting | Experimental result. HERO | |||||
ECHA, 2001, 6299228 | European Chemicals Agency (ECHA). Registration dossier: 3,3,4,4,5,5,6,6,6-nonafluorohexene (CASRN: 19430-93-4): Repeated dose toxicity: inhalation: 001 Key | Experimental result. HERO |
Showing studies 26-50 of 276